Stay updated on Anamorelin HCl in NSCLC-C: Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-C: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and may not all be about the study. Page revision label updated to v3.3.2, replacing the previous v3.2.0 wording.SummaryDifference0.1%

- Check17 days agoChange DetectedNotice about government funding lapse and operating status guidance was removed. The page's core study information, including eligibility and outcomes, remains unchanged.SummaryDifference0.3%

- Check32 days agoChange DetectedNo significant additions or deletions were observed. The ROMANA 3 study page content and structure appear unchanged.SummaryDifference0.2%

- Check60 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check68 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.7%

- Check82 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%

Stay in the know with updates to Anamorelin HCl in NSCLC-C: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.